Adequate bone marrow, hepatic, and renal function. ANC (Absolute Neutrophil Count) ≥ 1.5x10 9 cell/ml, platelets ≥75,000 /mm3, hemoglobin ≥ 9.0 g/dL, concentrations of total serum bilirubin within 1.5 x upper limit of normal (ULN), AST, ALT, CPK within 2.5 x ULN, and performed within 4 weeks prior to the first administration of Study Treatment. 5.